Literature DB >> 21237487

Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck--hallmark of epithelial-mesenchymal transition.

Nina Zidar1, Emanuela Boštjančič, Nina Gale, Nika Kojc, Mario Poljak, Damjan Glavač, Antonio Cardesa.   

Abstract

MicroRNAs are small, noncoding RNAs that regulate gene expression by posttranscriptional regulation of target genes. miR-200 family and miR-205 have been shown experimentally to regulate epithelial-mesenchymal transition. As epithelial-mesenchymal transition is the postulated pathogenetic mechanism in spindle cell carcinoma, we analyzed the expression of these microRNAs in spindle cell carcinoma of the head and neck in comparison to conventional squamous cell carcinoma of similar location and stage. We also analyzed the expression of classic and desmosomal cadherins, which are believed to be important targets during epithelial-mesenchymal transition. Forty-five cases of spindle cell carcinoma and 45 cases of squamous cell carcinoma of the head and neck were analyzed using real-time polymerase chain reaction for microRNAs, and immunohistochemistry for classic cadherins (E- and N-cadherins) and desmosomal cadherins. We found a significant down-regulation of the miR-200 family and miR-205, loss of desmosomal cadherins, and an altered expression of classic cadherins in spindle cell carcinoma in comparison to squamous cell carcinoma. Down-regulation of the miR-200 family and miR-205 strongly supports the postulated role of epithelial-mesenchymal transition in spindle cell carcinoma. These microRNAs act on transcription repressors that were also up-regulated in our cases of spindle cell carcinoma, both on mRNA and on protein levels. The result is not only an altered expression of classic cadherins in adherens junctions but also a complete loss of desmosomal cadherins.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21237487     DOI: 10.1016/j.humpath.2010.07.020

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  27 in total

1.  Carcinosarcoma and spindle cell carcinoma--monoclonal neoplasms undergoing epithelial-mesenchymal transition.

Authors:  Nina Zidar; Nina Gale
Journal:  Virchows Arch       Date:  2014-11-25       Impact factor: 4.064

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

3.  The role of epithelial-mesenchymal transition in squamous cell carcinoma of the oral cavity.

Authors:  Nina Zidar; Emanuela Boštjančič; Marija Malgaj; Nina Gale; Tadej Dovšak; Vojko Didanovič
Journal:  Virchows Arch       Date:  2017-07-12       Impact factor: 4.064

Review 4.  How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?

Authors:  Fernando López; Michelle D Williams; Antonio Cardesa; Jennifer L Hunt; Primož Strojan; Alessandra Rinaldo; Iain J Nixon; Juan P Rodrigo; Nabil F Saba; William M Mendenhall; Miquel Quer; Carlos Suárez; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-31       Impact factor: 2.503

5.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space.

Authors:  Nina Gale; Mario Poljak; Nina Zidar
Journal:  Head Neck Pathol       Date:  2017-02-28

6.  Downregulation of miR-429 contributes to the development of drug resistance in epithelial ovarian cancer by targeting ZEB1.

Authors:  Jing Zou; Ling Liu; Qi Wang; Fuqiang Yin; Zhijun Yang; Wei Zhang; Li Li
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

7.  MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.

Authors:  Linli Tian; Jiarui Zhang; Jingchun Ge; Hui Xiao; Jianguang Lu; Songbin Fu; Ming Liu; Yanan Sun
Journal:  Med Oncol       Date:  2013-12-03       Impact factor: 3.064

Review 8.  Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma.

Authors:  Justin A Bishop; Lester D R Thompson; Antonio Cardesa; Leon Barnes; James S Lewis; Asterios Triantafyllou; Henrik Hellquist; Goran Stenman; Jennifer L Hunt; Michelle D Williams; Pieter J Slootweg; Kenneth O Devaney; Douglas R Gnepp; Bruce M Wenig; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2015-03-11

9.  Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.

Authors:  Erin M Siegel; Steven Eschrich; Kathryn Winter; Bridget Riggs; Anders Berglund; Abidemi Ajidahun; Jeff Simko; Jennifer Moughan; Jaffer Ajani; Anthony Magliocco; Abul Elahi; Sarah Hoffe; David Shibata
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

Review 10.  MiR-200, a new star miRNA in human cancer.

Authors:  Xiangling Feng; Zhengming Wang; Rebecca Fillmore; Yaguang Xi
Journal:  Cancer Lett       Date:  2013-11-19       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.